MacroGenics
MGNX
#8649
Rank
NZ$0.44 B
Marketcap
NZ$6.98
Share price
1.23%
Change (1 day)
136.57%
Change (1 year)

Market capitalization of MacroGenics (MGNX)

Market cap: NZ$0.44 Billion

As of August 2026 MacroGenics has a market cap of NZ$0.44 Billion. This makes MacroGenics the world's 8649th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of MacroGenics from 2020 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$0.44 B152.86%
2025NZ$0.17 B-51.08%
2024NZ$0.35 B-61.9%
2023NZ$0.94 B45.23%
2022NZ$0.64 B-54.9%
2021NZ$1.44 B-19.16%
2020NZ$1.78 B

End of Day market cap according to different sources

On Aug 30th, 2026 the market cap of MacroGenics was reported to be:

NZ$0.44 Billion
by Nasdaq info icon info icon
NZ$0.44 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Pfizer
PFE
NZ$269.35 B 60,475.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$1.770 T 398,045.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$395.13 B 88,762.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
NZ$305.31 B 68,561.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$618.62 B 139,022.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$229.87 B 51,596.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
NZ$3.27 B 636.52%๐Ÿ‡บ๐Ÿ‡ธ USA